Step by Step

INTRODUCTION

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.25

Target Audience:

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Review SARS-CoV 2's virology and how it can be applied to vaccine preparation.
  • Discuss the Pfizer and Moderna vaccines that are going through emergency authorization.
  • Discuss how efficacy is measured and what is next in the vaccination creation process for COVID-19.

There is no educational content to this course. This course is designed to only administer the post-test and collect CME evaluations for the podcast associated with this training.

Suggested Additional Reading & Joint Accreditation Statement::

  1. Krammer, F. SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020). https://doi.org/10.1038/s41586-020-2798-3.
  2. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine
  3. https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study


Joint Accreditation Statement: This statement supersedes all other accreditation statements on this page.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.



The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:
John V. Williams, MD — Professor of Pediatrics, Microbiology & Molecular Genetics; Henry L. Hillman Professor of Pediatric Immunology; Chief, Division of Infectious Diseases; and Director, Institute for Infection, Inflammation, and Immunity in Children (i4Kids).
No relationships with industry relevant to the content of this educational activity have been disclosed.
Megan Culler Freeman MD, PhD — Senior Pediatric Infectious Diseases Fellow at UPMC Children’s Hospital of Pittsburgh.
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The University of Pittsburgh is an affirmative action, equal opportunity institution.